Delivra Health Brands Inc.

Delivra Health Brands Inc.

DHBUF
Delivra Health Brands Inc.US flagOther OTC
0.06
USD
-0.02
- -
1.84MMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.01
0.06
0.33
0.36
0.35
0.32
0.39
0.43
0.41
Basic EPS, GAAP
-0.21
-0.21
-0.26
-0.2
-0.17
-1.57
-1.05
-1.55
-3.72
-1.26
-0.28
-0.01
0.03
- -
Free Cash Flow per Basic Share
-0.23
-0.21
-0.25
-0.15
-0.16
-1.35
-1.15
-1.74
-1.15
-0.43
-0.18
-0.04
0.03
-0.02
Dividend per Share
- -
- -
- -
- -
- -
0.37
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.47
0.31
0.33
0.05
-0.11
3.69
7.59
3.93
0.55
-0.65
-0.86
-0.86
-0.72
-0.72
Tangible Book Value per Share
0.52
0.37
0.39
0.09
-0.05
4.3
5.95
3.29
1.12
0.17
-0.01
0.04
0.14
0.13
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
5
12
18
21
23
25
25
29
31
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
6
8
8
8
10
12
13
Operating Margin (%)
- -
- -
- -
- -
- -
-10,855.18
-1,251.93
-304.18
-201.64
-116.39
-73.87
-13.92
-5.74
-13.11
Depreciation Expense
- -
- -
- -
- -
- -
1
- -
1
3
3
2
1
1
1
Net Income, GAAP
- -
- -
- -
- -
- -
-8
-13
-28
-80
-29
-7
- -
1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
-11,110.24
-1,736.5
-465.6
-1,026.18
-358.7
-86.12
-1.88
7.08
-1.06
Working Capital
- -
- -
- -
- -
- -
15
61
27
9
3
1
2
6
6
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
2
2
2
Total Equity
- -
- -
- -
- -
- -
23
105
93
37
10
3
3
5
4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-11.34
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-5.45
-5.54
Return on Common Equity (%)
-35.99
-50.61
-82.22
-132.92
- -
- -
-22.72
-34.43
-193.5
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
- -
- -
- -
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
31
31
31
Market Capitalization
7
5
6

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
9
8
8
Cash, Cash Equivalents & STI
4
4
3
Accounts Receivable, Net
3
2
2
Inventories
1
1
2
Total Current Liabilities
3
2
2
Payables & Accruals
3
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-19,110.01%
-29.18%
53.26%
Free Cash Flow
1,998.45%
-75.46%
-166.96%
Net Income, GAAP
2,173.25%
-125.29%
-576.09%
Sales/Revenue/Turnover
- -
16.27%
26.42%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4
2
3
4
12
2025
2
1
3
3
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
-0.02
-0.01
- -
0.03
2025
-0.01
-0.03
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Gord Davey
Full Time Employees
22
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
999 Canada Place Vancouver BC Canada V6C 3E2
IPO Date
May 2, 2017
Business
Delivra Health Brands Inc. is a consumer packaged goods company specializing in health and wellness products, primarily focusing on sleep, pain, and anxiety relief. The company manufactures and distributes products under its flagship brands Dream Water® and LivRelief™, which include liquid sleep shots, gummies, sleep powder packets, and topical pain relief creams featuring a proprietary transdermal delivery system. Dream Water® offers multi-format sleep aid products containing ingredients such as melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan, while LivRelief™ provides topical creams targeting joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. Delivra also develops licensed cannabis-infused products, including creams with varying concentrations of CBD and THC. The company operates primarily in the United States and Canada, focusing on both e-commerce and retail channels, with significant penetration in regulated cannabis markets. Founded in 2014, Delivra Health Brands is headquartered in Vancouver, British Columbia, Canada. In the past two years, Delivra Health Brands has experienced continued revenue growth and operational advancements, including double-digit revenue increases for Dream Water® in both the U.S. and Canadian markets and for LivRelief™ in e-commerce. The company has expanded its retail footprint significantly by adding over 1,000 new stores and securing new national customers, broadening distribution channels. Delivra launched innovative products such as Dream Water Immunity Support Sleep Shots and new Dream Water gummies alongside strategic marketing campaigns. It has also revised its route-to-market strategy for licensed LivRelief™ Infused products to capture growth in both medical and recreational cannabis segments. Additionally, the company completed a share consolidation and is actively pursuing international expansion opportunities, supported by a strong product development pipeline aimed at enhancing consumer health solutions and shareholder value. These developments underscore Delivra Health Brands’ strategic commitment to growing its market presence and profitability in the health and wellness sector.

Company News

APIChatGPT
  • Delivra Health Brands launches LivRelief Itch Cream - ICYMI

  • Delivra Health Brands launches LivRelief Itch Cream - ICYMI

  • Delivra Health launches LivRelief Itch Relief Cream in Canada

  • Robinhood shares rise on launch of new blockchain network

  • Delivra Health Brands Launches LivRelief (TM) Itch Relief Cream in the Canadian Market

  • Delivra Health launches LivRelief Itch Relief Cream in Canada

  • Delivra Health brands reports e-commerce growth – ICYMI

  • Delivra Health and Its Brands Dream Water(R) and LivRelief(TM) Report Results for Third Quarter of Fiscal 2026

  • Berkshire Hathaway reports higher Q1 operating earnings under new CEO Greg Abel

  • Delivra Health Brands expands LivRelief with Peak Processing Solutions partnership - ICYMI

  • Delivra Health Brands expands LivRelief with Peak Processing Solutions partnership - ICYMI

  • Intel stock pops on strong first quarter report, upbeat guidance

  • Tesla sees analyst support on strong auto margins, AI strategy after Q1 beat

  • Delivra Health Brands inks licensing deal with Peak Processing Solutions to expand LivRelief in Canada

  • Delivra Health Brands inks licensing deal with Peak Processing Solutions to expand LivRelief in Canada

  • Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)

  • Delivra Health targets kids sleep market growth – ICYMI

  • Lindian brings Kangankunde closer to production with Tipume camp milestone

  • Delivra Health to launch Kids Sleep Gummies in US in June

  • Super Micro Computer stock tumbles after co-founder charged in Nvidia GPU smuggling case